Gsk (GLAXF) Net Income (2009 - 2026)

Gsk's Net Income history runs 18 years deep, the most recent figure standing at $3.3 billion for Q1 2026.

• In Q1 2026, Net Income rose 7.26% year-over-year to $3.3 billion; the TTM figure through Mar 2026 stood at $12.6 billion (up 31.15% YoY), while the FY2025 annual figure was $8.3 billion, changed N/A from the prior year.
• Net Income was $3.3 billion for Q1 2026 at Gsk, up from $2.7 billion in the prior quarter.
• In the past five years, Net Income ranged from a high of $11.9 billion in Q3 2022 to a low of $81.9 million in Q3 2024.
• Historically, Net Income has averaged $3.0 billion across 5 years, with a median of $2.7 billion in 2025.
• The sharpest annual moves came in 2024 and 2025: Net Income plunged 96.84% in 2024, then surged 4462.94% in 2025.
• A 5-year view of Net Income shows it stood at $733.1 million in 2022, then jumped by 687.27% to $5.8 billion in 2023, then dropped by 24.92% to $4.3 billion in 2024, then sank by 36.7% to $2.7 billion in 2025, then climbed by 20.38% to $3.3 billion in 2026.
• The last three Net Income figures came in at $3.3 billion (Q1 2026), $2.7 billion (Q4 2025), and $3.7 billion (Q3 2025), per Business Quant data.